Forum: Clinical Trials
03-04-2009, 11:05 AM
|
|
Replies: 0
Views: 4,581
Cx-4945
Cylene Pharmaceuticals Initiates Phase I Trial with CX-4945 – Breakthrough First-in Class Inhibitor of CK2
SAN DIEGO, CA - January 05, 2009
Cylene Pharmaceuticals announced today that it has...
|
